JOINT FILING AGREEMENT
Exhibit 99.1
The undersigned hereby agree that this statement on Schedule 13D with respect to the common stock of DUSA Pharmaceuticals, Inc. is, and any amendments hereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
|
Dated: November 19, 2012 |
| |
|
|
| |
|
|
| |
|
|
CARACO ACQUISITION CORPORATION | |
|
|
| |
|
|
| |
|
|
By: |
/s/ Xxxxx Xxxxx |
|
|
Name: |
Xxxxx Xxxxx |
|
|
Title: |
President |
|
|
|
|
|
|
|
|
|
|
SUN PHARMACEUTICAL INDUSTRIES LIMITED | |
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Xxxxx X. Xxxxxxxx |
|
|
Name: |
Xxxxx X. Xxxxxxxx |
|
|
Title: |
Managing Director |
|
|
|
|
|
|
|
|
|
|
SUN PHARMA GLOBAL, INC. | |
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Xxxxx Xxxxx |
|
|
Name: |
Xxxxx Xxxxx |
|
|
Title: |
Managing Director |
|
|
|
|
|
|
|
|
|
|
CARACO PHARMACEUTICAL LABORATORIES, LTD. | |
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Xxxxx Xxxxx |
|
|
Name: |
Xxxxx Xxxxx |
|
|
Title: |
Interim Chief Financial Officer |
|
|
| |
|
|
| |
|
|
XXXXX X. XXXXXXXX | |
|
|
| |
|
|
| |
|
|
/s/ Xxxxx X. Xxxxxxxx | |
|
|
Xxxxx X. Xxxxxxxx | |
